Pelvic inflammatory disease: a family practice perspective Original paper
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
-
Pelvic Inflammatory Disease (PID)
Pelvic Inflammatory Disease (PID)
OverviewPelvic Inflammatory Disease (PID) is a significant infection of the female upper reproductive tract, affecting the uterus, fallopian tubes, ovaries, and other surrounding pelvic structures. It is most commonly caused by sexually transmitted infections (STIs), particularly Chlamydia trachomatis and Neisseria gonorrhoeae. These infections ascend from the cervix or vagina into the upper genital tract, where […]
-
Divine Aleru
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
What was reviewed?
The paper reviewed key aspects of pelvic inflammatory disease (PID) management from the perspective of family practice physicians. The author assessed diagnostic accuracy, clinical presentations, and effective management strategies, focusing on risk factors, clinical criteria, diagnostic investigations, antimicrobial therapy, and prevention of PID, including asymptomatic forms linked to severe reproductive complications.
Who was reviewed?
This review examined family physicians’ diagnostic and treatment practices for PID, evaluating the challenges encountered in the primary care setting. It synthesized available clinical data, expert guidelines, and recommendations to enhance diagnostic accuracy and improve treatment outcomes among women managed in outpatient family practice environments.
What were the most important findings?
This review highlighted several important insights into PID management. PID, primarily an infection of the upper genital tract involving pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, anaerobic bacteria like Bacteroides, and aerobic bacteria such as Escherichia coli, poses diagnostic challenges due to its variable symptoms, ranging from mild discomfort to severe illness. A notable finding was the low diagnostic accuracy by clinical assessment alone, underscoring the necessity of adjunct diagnostic methods. Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) significantly improved diagnostic certainty when positive. However, even with these markers, clinical diagnosis alone remains insufficient; thus, laparoscopy or endometrial biopsy is recommended for uncertain cases to enhance diagnostic precision.
The review underscored that many family physicians inadequately adhere to antibiotic treatment guidelines, often prescribing single antibiotics despite recommendations advocating combination therapy. Recommended antibiotic regimens consistently include doxycycline or tetracycline combined with other antibiotics like cefoxitin, ampicillin, or ceftriaxone to adequately cover common pathogens. Compliance with antibiotic regimens remains critical, especially among adolescents who may require hospitalization to ensure effective treatment completion. The review stressed that asymptomatic PID, often caused by Chlamydia trachomatis, is an important precursor to infertility and ectopic pregnancy. Therefore, the review strongly advocated screening and early treatment of sexually transmitted infections (STIs), particularly chlamydial infections, as an essential preventative measure.
What are the greatest implications of this review?
The greatest implications involve the need for heightened clinical suspicion, better adherence to recommended multi-antibiotic treatments, improved diagnostic practices using biomarkers and laparoscopic confirmation when uncertainty exists, and proactive screening for asymptomatic infections. Emphasis on compliance and partner treatment to prevent recurrent infections also holds significant practical implications. Adopting these approaches in family practice will significantly reduce complications such as infertility, ectopic pregnancy, and chronic pelvic pain, thereby improving women’s overall reproductive health outcomes.
Infertility is the inability to conceive after 12 months of regular, unprotected sex. It affects both men and women and can be due to various physical, hormonal, or genetic factors. Treatments include medication, surgery, assisted reproductive technologies, and lifestyle changes.
Chronic Pelvic Pain (CPP) is persistent pain in the pelvic region lasting six months or longer, often multifactorial, impacting physical and emotional well-being, and associated with various medical conditions.